Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by TIMOTHY LOTZE and NIKITA SHUKLA.
TIMOTHY LOTZE
Connection Strength
0.918
NIKITA SHUKLA
  1. Inflammatory Diseases of the Central Nervous System. Neurol Clin. 2021 08; 39(3):811-828.
    View in: PubMed
    Score: 0.087
  2. Cerebellar Atrophy in Pediatric-Onset Opsoclonus-Myoclonus-Ataxia Syndrome: A Large International Cohort Study. Neurol Neuroimmunol Neuroinflamm. 2026 Sep; 13(5):e200619.
    View in: PubMed
    Score: 0.062
  3. Reply to: A Lethal Progressive Neuroinflammation Disguised as MOGAD Revealing a Final Diagnosis of Griscelli Syndrome: Regarding: MOGAD is the Most Common Cause of Isolated Optic Neuritis in Children. Ann Clin Transl Neurol. 2026 Aug; 13(8):1743-1744.
    View in: PubMed
    Score: 0.062
  4. MOGAD Is the Most Common Cause of Isolated Optic Neuritis in Children. Ann Clin Transl Neurol. 2026 May 04.
    View in: PubMed
    Score: 0.061
  5. Phenotypic Diversity and Outcomes in Pediatric NMDA Receptor Encephalitis: A 15-Year Retrospective Study from the Largest Children's Hospital in the United States. Adv Sci (Weinh). 2026 May; 13(28):e20313.
    View in: PubMed
    Score: 0.061
  6. Non-Syndromic Tumefactive Demyelinating Lesions in the Pediatric Population: Four Case Reports and Review of the Literature. Ann Child Neurol Soc. 2026 Mar; 4(1):87-94.
    View in: PubMed
    Score: 0.060
  7. Real-World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease-Modifying Therapy in Pediatric Multiple Sclerosis. Ann Neurol. 2026 03; 99(3):715-729.
    View in: PubMed
    Score: 0.059
  8. Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC Registry. J Child Neurol. 2026 Apr; 41(4):545-555.
    View in: PubMed
    Score: 0.058
  9. Epidemiology and Impact of Social Hardships in Children With Multiple Sclerosis in the United States. Neurology. 2024 Dec 10; 103(11):e209991.
    View in: PubMed
    Score: 0.055
  10. Association of nutritional intake with clinical and imaging activity in pediatric multiple sclerosis. Mult Scler. 2024 Jul; 30(8):1056-1065.
    View in: PubMed
    Score: 0.054
  11. Clinical and magnetic resonance imaging outcomes in pediatric-onset MS patients on fingolimod and ocrelizumab. Mult Scler Relat Disord. 2024 Jul; 87:105647.
    View in: PubMed
    Score: 0.053
  12. Fulminant Anti-Myelin Oligodendrocyte Glycoprotein-Associated Cerebral Cortical Encephalitis: Case Series of a Severe Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Phenotype. Pediatr Neurol. 2023 10; 147:36-43.
    View in: PubMed
    Score: 0.050
  13. Demographic Features and Clinical Course of Patients With Pediatric-Onset Multiple Sclerosis on Newer Disease-Modifying Treatments. Pediatr Neurol. 2023 08; 145:125-131.
    View in: PubMed
    Score: 0.050
  14. Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2. Mult Scler. 2023 04; 29(4-5):576-584.
    View in: PubMed
    Score: 0.049
  15. Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort. Mult Scler Relat Disord. 2023 Mar; 71:104573.
    View in: PubMed
    Score: 0.049
  16. Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder. Neurology. 2023 02 28; 100(9):e985-e994.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.